Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,790 | -4,566 | -3,536 | -1,641 | -16,069 |
| Depreciation Amortization | 28 | 20 | 13 | 7 | 77 |
| Accounts receivable | 49 | 38 | 42 | 22 | 5 |
| Other Working Capital | -85 | -124 | -14 | 45 | -222 |
| Other Operating Activity | 238 | 253 | 215 | -16 | 9,444 |
| Operating Cash Flow | $-5,559 | $-4,378 | $-3,281 | $-1,584 | $-6,765 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -110 | -20 | -19 | -19 | -19 |
| Investing Cash Flow | $-110 | $-20 | $-19 | $-19 | $-19 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 13,845 |
| Other Financing Activity | -158 | -114 | -79 | -34 | -711 |
| Financing Cash Flow | $-158 | $-114 | $-79 | $-34 | $13,134 |
| Beginning Cash Position | 16,277 | 16,277 | 16,277 | 16,277 | 9,926 |
| End Cash Position | 10,449 | 11,765 | 12,899 | 14,639 | 16,277 |
| Net Cash Flow | $-5,828 | $-4,512 | $-3,378 | $-1,638 | $6,351 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,559 | -4,378 | -3,281 | -1,584 | -6,765 |
| Capital Expenditure | -111 | -20 | -19 | -19 | -19 |
| Free Cash Flow | -5,670 | -4,399 | -3,299 | -1,603 | -6,783 |